Melanocytic naevi of lip

CD2_BENIGN_MELANOCYTIC_LIP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.0& Hospital discharge: ICD-9 — 2160A Cause of death: ICD-10 — D22.0& Cause of death: ICD-9 — 2160A 2 out of 7 registries used, show all original rules.	319
4. Check minimum number of events None	319
5. Include endpoints None	319
6. Filter based on genotype QC (FinnGen only)	311

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus (cutis) labii (oris)

NAME	CD2_BENIGN_MELANOCYTIC_LIP
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D220
HD_ICD_9	2160A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D220
COD_ICD_9	2160A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of lip based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	2143	1358	781
Only index persons	2030	1302	728
Unadjusted period prevalence (%)
Whole population	0.03	0.04	0.02
Only index persons	0.04	0.05	0.03
Median age at first event (years)
Whole population	39.45	40.56	37.57
Only index persons	38.35	40.23	35.00

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	311	234	77
Unadjusted period prevalence (%)	0.07	0.08	0.04
Median age at first event (years)	44.11	42.47	49.11

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
319: Matched controls
3190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D22.0

ICD-10 Finland

Melanocytic naevi of lip

4503599627370496.0

307.7

291

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

8.4

54.4

128

2160A

ICD-9 Finland

Benign neoplasm of skin, Skin of lip[HUULEN IHON BENIGNI KASVAIN,NAEVUS PIGMENTOSUS]

+∞

29.6

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

6.5

28.9

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

5.8

24.2

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

5.9

23.2

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

4.3

18.4

137

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.8

12.3

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

9.3

12.3

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

9.5

12.0

EAA10

NOMESCO Finland

Excision of lesion of lip

17.4

10.0

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

3.6

9.5

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

7.5

8.9

9733

FHL

Excision of skin change in operating room or anesthesia

7.7

7.8

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

3.8

7.2

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

7.3

6.3

S82

ICPC

Naevus/mole

2.2

6.1

261

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

145

1070

1.65

4.58

2.5

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

309

1.94

4.43

3.1

2.2

23.80

22.51

0.27

269

(3009508) Creatinine [Moles/volume] in Urine

100

691

1.65

3.98

3.1

3.0

6.69

7.35

mmol/l

0.67

590

(3012516) Albumin [Mass/volume] in Urine

619

1.61

3.38

3.3

3.1

2307.94

154.57

mg/l

1.00

396

(3020682) Albumin/Creatinine [Ratio] in Urine

660

1.58

3.23

3.9

3.7

9.15

7.40

mg/mmol

0.14

402

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

121

932

1.48

2.82

2.0

1.9

99.18

95.35

pmol/l

0.33

465

(3024561) Albumin [Mass/volume] in Serum or Plasma

130

1027

1.45

2.62

3.7

4.1

36.73

36.10

g/l

0.70

124

965

(40760892) CBC W Ordered Manual Differential panel - Blood

150

1221

1.43

2.56

6.9

5.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

7.23

2.56

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

7.23

2.56

1.2

1.1

—

(3013115) Eosinophils [#/volume] in Blood

162

1339

1.43

2.53

6.3

5.7

0.21

0.18

e9/l

1.08

141

1184

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

366

1.61

2.47

2.7

2.8

2.10

3.03

e6/l

0.47

190

(3013707) Erythrocyte sedimentation rate by Westergren method

226

1991

1.46

2.45

4.2

3.9

12.06

10.95

mm/h

0.51

212

1845

(3001604) Monocytes [#/volume] in Blood

156

1293

1.40

2.34

6.3

5.4

0.53

0.55

e9/l

0.74

133

1128

(3007853) Bacteria identified in Skin by Aerobe culture

265

1.67

2.32

2.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

1040

0.68

2.29

3.0

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

5.62

2.22

1.0

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

207

1811

1.41

2.21

4.7

4.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

130

1.91

2.19

1.5

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

168

1.80

2.16

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

3.74

2.16

1.0

—

(3006315) Basophils [#/volume] in Blood

155

1296

1.38

2.15

6.3

5.4

0.04

e9/l

0.46

132

1131

(1617658) Protocol used for examination of sentinel lymph nodes

2.96

2.09

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

3.13

2.02

1.4

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

2.13

2.00

1.6

1.4

—

(3019198) Lymphocytes [#/volume] in Blood

157

1329

1.36

1.96

6.4

5.4

1.97

2.01

e9/l

0.09

141

1191

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

106

1.95

1.5

196.91

246.99

miu/ml

0.32

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

286

1.58

1.95

1.7

2.6

7.14

7.76

umol/l

0.14

241

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

109

875

1.37

1.89

3.3

3.0

30.23

29.44

u/l

0.16

102

839

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

602

1.42

1.86

2.3

2.0

2.74

3.06

mg/l

0.63

514

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

392

1.49

1.84

2.6

0.83

0.89

e6/l

0.09

216

(3019550) Sodium [Moles/volume] in Serum or Plasma

282

2649

1.56

1.76

16.3

13.8

139.41

139.71

mmol/l

1.05

275

2570

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

232

2107

1.37

1.73

4.6

4.1

14.52

14.60

pmol/l

0.20

213

1937

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.61

1.62

2.6

—

(3002256) Pathology report gross observation

325

1.49

1.61

1.5

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

267

2492

1.44

1.61

5.7

4.8

1.89

2.29

mu/l

0.39

252

2298

(3022096) Basophils/100 leukocytes in Blood

138

1172

1.31

1.59

6.7

5.4

0.70

0.68

0.26

127

1085

(3013650) Neutrophils [#/volume] in Blood by Automated count

174

1529

1.30

1.55

9.7

8.8

4.16

4.03

e9/l

0.35

150

1341

(3044242) Glucose [Moles/volume] in Arterial blood

3.37

1.53

2.0

6.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

281

2656

1.49

1.50

17.0

13.8

3.95

mmol/l

0.06

275

2575

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

314

1.47

2.1

1.8

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

155

1348

1.29

1.47

5.4

5.6

12.14

10.46

umol/l

0.81

149

1281

(3037522) Nuclear Ab [Titer] in Serum

375

1.43

1.46

1.6

1.4

236.92

509.57

titre

2.05

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2.07

1.45

1.2

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

566

1.35

1.40

3.3

3.5

—

(40768793) Breast Pathology biopsy report

1.87

1.38

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.87

1.38

1.3

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

415

1.39

1.37

1.6

1.7

1357.96

1242.27

nmol/l

0.24

301

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.82

1.35

1.3

2.0

3.23

3.64

g/l

1.31

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.82

1.35

1.3

2.0

6.97

7.48

g/l

0.74

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.82

1.35

1.3

2.0

—

(36660697) Celiac disease serology panel - Serum

220

1.51

1.29

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.82

1.29

1.2

2.1

2.93

3.05

g/l

0.21

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

501

1.35

1.28

1.3

1.33

10.45

u/ml

3.41

194

(3026389) Candida sp identified in Specimen by Organism specific culture

2.25

1.25

1.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

217

1992

1.28

1.25

7.6

6.9

75.99

76.79

u/l

0.09

203

1875

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

143

1250

1.26

1.24

6.6

5.9

1.22

mmol/l

0.43

125

1045

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

116

1.68

1.24

5.7

11.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

116

1.68

1.24

3.4

2.2

—

(3026008) Bacteria identified in Urine by Culture

781

1.29

1.23

3.4

2.7

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

126

1088

1.26

1.21

2.3

80.25

76.57

nmol/l

1.03

115

983

(3001122) Ferritin [Mass/volume] in Serum or Plasma

142

1244

1.25

1.20

3.4

2.7

102.71

90.47

ug/l

0.43

137

1155

(3006504) Eosinophils/100 leukocytes in Blood

140

1225

1.25

1.20

6.6

5.4

3.18

2.76

1.02

129

1144

(3019897) Erythrocyte distribution width [Ratio] by Automated count

2.08

1.16

2.4

1.9

13.75

13.23

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

2.52

1.15

1.4

1.2

—

94.40

—

(3019069) Monocytes/100 leukocytes in Blood

140

1231

1.24

1.13

6.8

5.6

8.12

8.27

0.27

130

1153

(3023520) Reticulocytes [#/volume] in Blood

152

1.55

1.12

2.8

2.7

66.08

69.28

e9/l

0.23

116

(3042936) Bacteria identified in Isolate by Culture

324

1.38

1.10

2.4

2.1

—

(3038026) Centromere Ab [Units/volume] in Serum

2.40

1.09

1.4

1.1

—

(40768797) Stomach Pathology biopsy report

343

1.36

1.08

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

252

2375

1.29

1.07

20.0

14.9

14.90

14.69

0.23

247

2344

(3023323) Follitropin [Units/volume] in Serum or Plasma

146

1.54

1.06

1.2

1.3

27.01

27.56

iu/l

0.02

124

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

292

2813

1.45

1.05

11.4

9.5

25.71

25.00

u/l

0.36

284

2725

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

410

1.32

1.00

2.0

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.88

0.97

1.5

1.4

—

(3052851) Hemolysis interference index of Serum or Plasma

1.72

0.96

3.9

3.0

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

368

1.33

0.96

2.1

2.0

—

(40761511) CBC panel - Blood by Automated count

290

2798

1.40

0.95

15.9

11.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

170

0.57

0.93

2.0

1.7

—

(3018010) Neutrophils/100 leukocytes in Blood

139

1242

1.21

0.92

6.4

5.3

58.30

56.63

1.00

129

1164

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

211

1.41

0.92

2.6

68.50

69.07

ml/min/173m2

0.03

(3002030) Lymphocytes/100 leukocytes in Blood

141

1262

1.21

0.92

6.7

5.5

28.24

28.77

0.24

131

1187

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

2.16

0.92

1.2

1.6

—

(3007461) Platelets [#/volume] in Blood

304

2961

1.57

0.91

23.8

18.4

259.57

255.65

e9/l

0.53

299

2895

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

453

1.29

0.91

3.3

3.1

410.63

150.66

ng/l

0.65

316

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

809

1.23

0.90

2.0

2.3

53.16

62.61

u/l

0.84

753

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

119

1.54

0.90

1.8

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

2.09

0.89

1.0

1.2

—

nmol/l

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

265

1.36

0.89

3.3

3.9

2.21

49.97

ug/l

0.93

216

(3035941) MCH [Entitic mass]

304

2963

1.55

0.88

23.7

18.3

30.07

30.17

0.46

299

2922

(3024731) MCV [Entitic volume]

304

2963

1.55

0.88

23.7

18.3

90.37

90.67

0.58

299

2922

(4200892) Spirometry reversibility

179

1.43

0.87

1.7

1.3

—

(3010813) Leukocytes [#/volume] in Blood

304

2964

1.55

0.86

23.8

18.4

6.78

6.66

e9/l

0.44

298

2891

(3026361) Erythrocytes [#/volume] in Blood

304

2964

1.55

0.86

23.8

18.4

4.47

4.48

e12/l

0.12

298

2893

(3021788) Differential panel - Synovial fluid

1.95

0.85

2.3

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

121

1.52

0.84

1.6

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

249

2365

1.24

0.84

5.9

5.2

39.31

39.17

mmol/mol

0.09

228

2218

(3000963) Hemoglobin [Mass/volume] in Blood

304

2966

1.53

0.83

23.9

18.5

133.68

134.41

g/l

0.48

299

2925

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1.76

0.83

1.4

1.1

—

(4035726) Immunohistochemistry procedure

216

1.38

0.82

1.5

1.4

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

278

2678

1.30

0.80

14.7

12.3

18.07

21.05

mg/l

1.23

212

2079

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

0.79

0.0

1.3

—

(40768800) Prostate Pathology biopsy report

0.00

0.79

0.0

1.2

—

(3018095) Leukocytes [#/volume] in Urine

103

906

1.20

0.79

4.0

3.6

110.62

73.79

e6/l

0.28

625

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1.54

0.77

2.5

1.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

327

1.29

0.75

1.7

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

100

1.52

0.74

1.3

1.6

—

10.08

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

503

1.24

0.74

1.2

1.3

38.07

27.24

iu/ml

0.21

161

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

107

0.55

0.74

1.5

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

644

1.22

0.74

2.6

3.0

2921.96

1140.07

ng/l

0.40

544

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1.57

0.73

1.2

2.1

9.92

10.49

g/l

0.21

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

2.02

0.73

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

2.02

0.73

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

2.02

0.73

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

2.02

0.73

1.2

1.0

—

titre

—

(3009542) Hematocrit [Volume Fraction] of Blood

303

2962

1.46

0.72

23.1

18.4

39.59

40.05

0.61

276

2804

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

262

2515

1.23

0.72

4.8

4.2

5.72

5.82

mmol/l

0.96

244

2312

(3030467) Casts [#/volume] in Urine by Automated count

684

1.21

0.71

3.3

2.9

0.75

0.44

e6/l

0.73

517

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

0.71

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

0.71

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

0.71

1.2

1.1

—

(3003396) Base excess in Arterial blood by calculation

258

1.31

0.70

4.7

8.3

1.77

1.32

mmol/l

0.32

211

(3014576) Chloride [Moles/volume] in Serum or Plasma

285

1.30

0.70

5.5

5.9

101.33

104.33

mmol/l

1.68

285

(3011288) Drugs identified in Urine by Screen method

1.55

0.70

1.3

1.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

564

1.21

0.68

1.5

21.85

21.57

nmol/l

0.06

467

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

162

1.38

0.68

1.2

1.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

202

0.68

1.8

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

1.64

0.67

1.6

3.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

1.64

0.67

1.3

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

135

1232

1.17

0.66

2.7

2.4

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

125

1134

1.17

0.66

5.7

5.4

1.22

mmol/l

0.02

114

1037

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

728

1.19

0.65

2.2

2.0

222.62

240.33

u/l

0.05

692

(3019060) Gas panel - Arterial blood

138

1.40

0.64

3.8

7.4

—

(4281824) Cell count and differential, peritoneal fluid

1.74

0.64

1.0

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

299

1.27

0.63

4.9

4.1

21.54

22.16

0.10

129

(3002582) Erythrocytes [#/volume] in Urine

750

1.18

0.63

3.4

3.1

47.20

131.38

e6/l

0.46

578

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1.65

0.62

2.1

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.61

0.62

1.5

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

485

1.21

0.62

1.8

1.7

494.96

30073797.84

pmol/l

0.78

409

(3013512) EKG study

695

1.18

0.60

3.7

3.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

0.00

0.60

0.0

1.1

—

1.06

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.60

0.0

1.7

—

(40761535) Cells panel - Urine sediment

185

0.69

0.60

3.8

3.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

114

1.42

0.60

1.7

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

114

1.42

0.60

1.7

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

256

1.28

0.59

4.8

8.4

5.36

5.23

kpa

0.28

248

(3027801) Oxygen [Partial pressure] in Arterial blood

256

1.28

0.59

4.8

8.4

12.38

12.73

kpa

0.11

248

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.59

0.0

1.6

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

1.16

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

211

1.31

0.59

1.3

2.4

0.23

0.22

g/l

0.20

196

(40768443) Skin Pathology biopsy report

106

1.44

0.59

1.5

1.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

191

1800

1.15

0.58

3.0

2.9

46.43

40.46

u/l

0.51

182

1698

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

115

1.41

0.58

1.7

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

115

1.41

0.58

1.7

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1.49

0.57

2.3

1.9

—

(3044889) 12 lead EKG panel

189

1784

1.15

0.55

3.8

3.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

672

1.17

0.55

1.3

1.2

0.60

2.03

u/ml

1.27

181

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

250

1.27

0.55

2.3

2.2

32.00

28.66

u/l

0.51

212

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1.59

0.54

1.2

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1.50

0.54

1.2

2.2

38.44

38.19

g/l

0.05

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1.44

0.52

2.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.51

0.52

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.51

0.52

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.51

0.52

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.51

0.52

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.51

0.52

1.2

—

(3021589) Normoblasts [#/volume] in Blood

130

1202

1.14

0.51

11.5

8.6

0.00

e9/l

0.39

100

998

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

190

0.72

0.51

1.9

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

140

1302

1.13

0.50

3.8

3.5

0.00

estimate

-0.00

289

(3022621) pH of Urine by Test strip

166

0.71

0.49

2.1

2.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

287

0.79

0.48

2.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

451

1.18

0.48

2.4

2.8

2.42

2.45

mmol/l

0.90

401

(3007164) IgA [Mass/volume] in Serum or Plasma

595

1.16

0.46

1.4

1.3

2.09

2.23

g/l

0.33

358

(3037756) Immunofixation for Serum or Plasma

1.44

0.46

1.3

1.9

—

(3037121) Protein [Mass/volume] in Urine

1.44

0.46

1.5

3.4

0.26

0.23

g/l

—

(3048689) Calprotectin [Mass/mass] in Stool

350

0.81

0.46

1.8

2.3

59.10

122.53

ug/g

1.89

272

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

904

0.87

0.45

2.9

3.4

25.83

69.20

ng/l

0.52

580

(3026782) Osmolality of Urine

501

1.17

0.45

4.2

2.6

549.47

535.12

mosm/kgh2o

0.16

431

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

139

1.31

0.44

1.6

2.3

9155.70

2204.33

u/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

579

1.15

0.44

1.4

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

104

1.36

0.44

3.9

2.0

0.70

0.67

0.11

104

(3015377) Calcium [Moles/volume] in Serum or Plasma

860

1.13

0.43

3.1

2.37

2.35

mmol/l

0.47

774

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1.62

0.43

1.0

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.62

0.43

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

1.62

0.43

3.2

3.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.65

0.43

1.5

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

117

1086

1.12

0.42

15.8

11.6

1.33

1.21

inr

0.54

330

(3035285) Chloride [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

102.00

106.03

mmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1.57

0.42

1.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

1.57

0.42

4.0

2.3

3.96

3.98

mmol/l

—

(3005033) Fetal Nuchal fold Thickness US

1.37

0.42

1.6

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.37

0.42

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1.39

0.42

1.1

1.8

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

532.11

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.41

0.0

1.0

—

34.67

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

0.00

0.41

0.0

1.1

—

550245.00

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.0

—

260.33

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.41

0.0

2.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.1

—

(3015183) Erythrocyte sedimentation rate

0.00

0.41

0.0

1.2

—

(3019230) Fractional oxyhemoglobin in Venous blood

1.48

0.40

1.2

1.4

68.02

58.83

—

(3021901) Oxygen saturation in Capillary blood

1.48

0.40

1.8

2.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.35

0.40

1.7

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

104

0.67

0.40

1.4

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1.32

0.40

1.8

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

124

1.31

0.39

1.8

1.5

—

(3015736) pH of Urine

114

1061

1.12

0.39

3.6

3.3

5.86

5.84

—

(3021601) Nitrite [Presence] in Urine by Test strip

139

1308

1.11

0.39

5.5

4.8

0.00

estimate

-0.00

268

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.39

0.0

1.7

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.39

0.38

1.2

1.0

—

(3029937) Albumin [Presence] in Urine by Test strip

707

0.88

0.37

4.2

3.8

0.00

estimate

-0.00

270

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.47

0.36

1.3

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.47

0.36

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.33

0.36

1.7

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1.44

0.35

1.2

1.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.44

0.35

1.2

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

812

1.12

0.35

2.2

2.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1.40

0.35

1.2

1.3

—

(36304419) Bacteria [Presence] in Urine

686

1.12

0.35

3.2

2.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.38

0.35

1.1

1.2

—

(3022145) Colonoscopy Study observation

317

0.84

0.34

1.5

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.68

0.33

1.0

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

220

1.20

0.33

3.1

2.9

0.74

0.77

ug/l

0.10

135

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

270

2644

1.14

0.33

5.2

4.5

2.73

2.82

mmol/l

0.95

250

2455

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

194

1869

1.10

0.32

3.4

—

(3019150) Specific gravity of Urine by Refractometry

555

1.12

0.31

4.0

3.7

1.01

1.02

kg/l

—

(3003694) ABO and Rh group [Type] in Blood

781

0.90

0.31

1.6

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

356

0.86

0.31

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

207

0.81

0.31

1.8

1.5

—

(3009261) Glucose [Presence] in Urine by Test strip

139

1321

1.09

0.31

3.8

3.6

0.00

0.01

estimate

0.50

259

(3028300) Cannabinoids [Presence] in Urine

120

1.26

0.30

1.3

1.5

—

(3027008) Opiates [Presence] in Urine

120

1.26

0.30

1.3

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

120

1.26

0.30

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

112

1.26

0.29

1.4

1.5

—

(3004588) Protein electrophoresis panel - Serum or Plasma

149

1.22

0.28

1.3

2.3

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

321

0.86

0.28

1.4

—

(40758558) Short blood count panel - Blood

676

1.10

0.28

8.0

7.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

254

2488

1.10

0.26

4.1

3.7

1.34

1.25

mmol/l

0.40

232

2295

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

283

1.15

0.25

7.2

6.4

—

(3049717) Cytology report of Urine Cyto stain

1.24

0.25

2.4

2.6

—

(4034850) Laboratory test

1.17

0.24

9.7

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.29

0.24

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

0.74

0.24

1.0

1.1

9.38

12.48

u/l

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.73

0.24

1.3

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

604

1.10

0.24

2.8

2.4

319.54

5705.41

umol/l

2.53

530

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.29

0.23

2.2

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.29

0.23

2.2

1.4

—

(3000330) Specific gravity of Urine by Test strip

125

1.21

0.23

6.0

3.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

152

1465

1.07

0.22

3.8

4.4

6.77

6.54

mmol/l

0.62

132

1339

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

334

1.12

0.22

1.4

1.6

1.40

0.02

294

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

596

1.09

0.22

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

283

0.87

0.22

1.4

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1.22

0.22

1.4

1.2

—

114.13

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.22

0.22

1.4

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.19

0.21

8.2

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.19

0.21

1.0

1.1

—

(3047189) Immunofixation for 24 hour Urine

0.00

0.21

0.0

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.21

0.0

4.3

—

222.45

—

(3020650) Glucose [Presence] in Urine

0.00

0.21

0.0

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.21

0.0

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1.17

0.21

1.2

—

(3024928) Oxygen saturation in Venous blood

1.17

0.21

1.2

2.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.21

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.3

—

184.74

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

867

1.07

0.18

3.2

3.0

—

(40761536) Microorganisms panel - Urine sediment

237

0.88

0.18

2.8

3.6

—

(1002224) Polysomnography panel

121

0.82

0.18

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

263

2594

1.08

0.17

4.6

4.1

1.53

mmol/l

0.00

244

2405

(3020961) Endomysium IgA Ab [Titer] in Serum

152

0.85

0.17

1.1

—

106.20

—

(3003327) Ova and parasites identified in Stool by Light microscopy

101

1.20

0.17

2.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

1.18

0.16

9.8

3.8

—

(3027944) Amphetamines [Presence] in Urine

120

1.17

0.16

1.4

1.5

—

(3020891) Body temperature

1.20

0.16

5.8

3.9

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1.16

0.15

1.2

1.3

—

3.23

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.14

0.15

1.2

1.3

—

3.11

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

188

1.13

0.15

2.9

22.43

37.27

u/ml

0.97

180

(3002179) Metamyelocytes/100 leukocytes in Blood

188

1.13

0.15

9.2

3.7

0.56

0.76

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

490

1.07

0.14

2.0

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

248

1.10

0.13

2.1

1.7

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

701

1.05

0.12

1.7

1.6

1.26

1.36

mmol/l

0.62

597

(46235355) HIV 1 and 2 tests - Meaningful Use set

596

0.95

0.11

2.2

2.0

—

(3018418) pH of Serum or Plasma

782

1.05

0.11

4.9

3.5

7.40

0.14

147

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

263

2606

1.05

0.10

4.7

4.1

4.71

4.76

mmol/l

0.32

248

2431

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.11

0.10

8.6

2.6

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.11

0.10

1.4

1.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

252

1.08

0.09

2.3

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.06

0.09

1.8

2.4

8.10

8.23

kpa

—

(3000991) Gas panel - Venous blood

184

1.09

0.09

6.6

6.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

175

0.91

0.08

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

0.80

0.08

1.8

2.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.79

0.08

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1.13

0.07

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.84

0.07

1.0

1.2

—

56.50

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.84

0.07

1.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.80

0.07

2.2

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

108

1.12

0.07

1.0

2.0

—

(3021440) Promyelocytes/100 leukocytes in Blood

196

1.08

0.07

9.8

4.0

0.00

0.16

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.87

0.07

2.3

2.0

—

(3023368) Bacteria identified in Blood by Culture

592

1.04

0.06

7.3

4.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

587

0.96

0.06

1.8

1.7

1.11

0.97

mg/l

0.25

446

(3000494) Fungus identified in Specimen by Culture

314

0.95

0.06

1.6

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

250

2483

1.03

0.05

14.3

11.5

82.50

84.55

ml/min/173m2

0.74

205

2024

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

238

1.05

0.05

1.7

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

288

1.05

0.04

5.2

4.2

32.30

32.07

0.04

192

(3008898) HLA-B27 [Presence]

150

1.07

0.04

1.0

1.1

—

(3000492) Spirometry study

249

1.05

0.04

1.7

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

528

1.03

0.03

2.9

2.5

6.21

7.28

e6/l

0.23

478

(3041096) Erythrocytes [Presence] in Urine by Automated

768

1.02

0.03

3.4

3.1

—

(3019225) pH of Specimen

211

1.05

0.03

3.6

4.0

—

(3045414) Leukocytes [Presence] in Urine

112

1.07

0.03

1.7

1.8

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

183

1.04

0.01

1.8

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

243

1.03

0.01

4.4

3.3

—

(3025941) Bacteria identified in Stool by Culture

164

1.04

0.00

1.2

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

138

1.02

0.00

4.8

5.0

24.78

25.13

mmol/l

0.14

138

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

602

1.00

0.00

2.3

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

351

1.00

0.00

2.3

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1.03

0.00

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1.03

0.00

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

103

0.97

0.00

1.4

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

143

0.98

0.00

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

227

1.01

0.00

1.1

1.2

50.04

180.12

iu/ml

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

206

1.02

0.00

1.8

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

102

1025

0.99

0.00

4.1

3.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.00

0.00

2.5

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

1.8

—

(3003129) Base excess in Capillary blood by calculation

0.00

-0.00

0.0

1.0

—

3.70

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

3.6

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

2.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

-0.00

0.0

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.94

-0.00

1.5

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.00

-0.00

0.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

-0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

1.02

-0.00

3.6

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.86

-0.00

1.0

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.0

—

1.19

—

(3044007) Cell count panel - Peritoneal fluid

0.00

-0.00

0.0

1.0

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

0.97

-0.00

2.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

190

1.00

-0.00

10.1

3.9

0.00

0.33

—

(3017181) Myelocytes/100 leukocytes in Blood

210

1.00

-0.00

9.8

3.8

0.60

0.83

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.96

-0.00

1.6

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.00

-0.00

0.0

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

-0.00

0.0

2.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.96

-0.00

1.6

1.4

—

(3048879) Bone marrow aspiration report

0.00

-0.00

0.0

1.8

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

100.29

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

3.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

0.00

-0.00

0.0

1.4

—

(3022313) Gas panel - Capillary blood

0.94

-0.00

1.4

2.9

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

-0.00

0.0

1.0

—

(3011436) Histone Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

-0.00

0.0

1.8

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

0.00

-0.00

0.0

1.0

—

6.67

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

0.00

-0.00

0.0

2.0

—

1.19

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.3

—

1.42

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3035880) pH of Pleural fluid

0.00

-0.00

0.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

1.91

—

(3044290) Cell count panel - Cerebral spinal fluid

0.96

-0.00

1.2

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.5

—

(3036489) Thrombin time

1.00

-0.00

1.7

1.9

20.11

21.23

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.00

-0.00

0.0

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

10.66

—

(3051593) INR in Capillary blood by Coagulation assay

0.00

-0.00

0.0

14.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.4

—

15.10

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

0.94

-0.00

2.8

25.52

24.55

mmol/l

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

-0.00

0.0

1.8

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_MELANOCYTIC_LIP and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_LIP	0.855 [0.68, 1.07]	0.173
Birth year	1.0 [0.99, 1.01]	0.977

During the follow-up period (1.1.1998 — 31.12.2019), 98 out of 1211 females with CD2_BENIGN_MELANOCYTIC_LIP died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_MELANOCYTIC_LIP	1.024 [0.79, 1.32]	0.855
Birth year	0.988 [0.98, 1.0]	0.015

During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 689 males with CD2_BENIGN_MELANOCYTIC_LIP died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_MELANOCYTIC_LIP.

N-year risk	Females	Males
1	0.102%	0.184%
5	0.639%	1.242%
10	1.545%	3.197%
15	2.804%	5.88%
20	4.939%	10.045%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_LIP – Melanocytic naevi of lip

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Melanocytic naevi of lip

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints